ReBio is a biotechnology business in the early stages of research that has created SiSu®, a revolutionary, proprietary formulation technology that addresses the safety and efficacy issues that other sustained release approaches have failed to address. ReBio has developed a new franchise based on Sisu® to revolutionise the treatment of vision-threatening chronic eye disorders. Its headquarters are in Cranleigh, Surrey, United Kingdom, where it was created in 2014.
$ 5 Millions - $ 10 Millions
Leave a Reply